# FDA Inspection 674205 - Shandong Anxin Pharmaceutical Co., Ltd. - June 25, 2010

Source: https://www.keypedia.com/records/fda_inspections/shandong-anxin-pharmaceutical-co-ltd/8a7fe28f-841a-4219-bbd7-aabf61150aeb
Source feed: FDA_Inspections

> FDA Inspection 674205 for Shandong Anxin Pharmaceutical Co., Ltd. on June 25, 2010. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 674205
- Company Name: Shandong Anxin Pharmaceutical Co., Ltd.
- Inspection Date: 2010-06-25
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1157432 - 2019-09-18](https://www.keypedia.com/records/fda_inspections/shandong-anxin-pharmaceutical-co-ltd/cab8781f-ebf8-42a5-a505-40af512daf1b)
- [FDA Inspection 1028356 - 2017-09-01](https://www.keypedia.com/records/fda_inspections/shandong-anxin-pharmaceutical-co-ltd/0bc43ad6-482b-4975-8dba-ededbb405f4a)
- [FDA Inspection 929464 - 2015-06-02](https://www.keypedia.com/records/fda_inspections/shandong-anxin-pharmaceutical-co-ltd/4614391b-c58d-4e10-a99f-1b6f17509821)
- [FDA Inspection 851840 - 2013-09-27](https://www.keypedia.com/records/fda_inspections/shandong-anxin-pharmaceutical-co-ltd/73ebff4d-36fb-4907-8298-f44c31161d5a)

Company: https://www.keypedia.com/companies/shandong-anxin-pharmaceutical-co-ltd/1bbdc465-0634-4e76-994f-a57ad864fc33

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c